Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Preferred Stock Liabilities (2017 - 2018)

Altimmune (ALT) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $510083.0 as the latest value for Q2 2018.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A to $510083.0 in Q2 2018 year-over-year; TTM through Jun 2018 was $510083.0, a N/A change, with the full-year FY2017 number at $9.3 million, changed N/A from a year prior.
  • Preferred Stock Liabilities was $510083.0 for Q2 2018 at Altimmune, down from $6.0 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $9.3 million in Q4 2017 to a low of $510083.0 in Q2 2018.